Who is sponsoring NCT01333150?

NCT01333150 is sponsored by University of Aarhus.

What drugs are being tested in NCT01333150?

Interventions in NCT01333150: Propranololhydrochlorid, Placebo.

What condition does NCT01333150 study?

NCT01333150 studies Temporomandibular Joint Disorders, Myofascial Temporomandibular Disorders.

Is NCT01333150 still recruiting?

NCT01333150 is currently status unknown. Last updated 23 March 2012.

Last reviewed 2012-03-23 · How we verify

NCT01333150

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effects of a Low-dose Propranolol on a Stress Induced Autonomic Response and on Muscle Pain

Status unknown NA Last updated 23 March 2012

What this trial tests

NA trial testing Propranololhydrochlorid in Temporomandibular Joint Disorders in 16 participants. Status unknown.

Timeline

1 August 2011

Primary endpoint
1 September 2012

1 September 2012

Quick facts

Lead sponsor	University of Aarhus
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	double
Primary purpose	basic science
Enrollment	16
Start date	1 August 2011
Primary completion	1 September 2012
Estimated completion	1 September 2012
Sites	2 locations across Denmark

Drugs / interventions tested

Propranololhydrochlorid — full drug profile →
Placebo

Conditions studied

Temporomandibular Joint Disorders — all drugs for Temporomandibular Joint Disorders →
Myofascial Temporomandibular Disorders — all drugs for Myofascial Temporomandibular Disorders →

Sponsor

University of Aarhus

Who can join

Adults 18 to 60, female only, with Temporomandibular Joint Disorders or Myofascial Temporomandibular Disorders. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Pain intensity
Time frame: Participants will be asked to score their actual pain level in both of the two experimental sessions they will participate in; an expected average of two weeks between the two sessions
Numeric Rating Scale 0-10

Sponsor's own description

The project's primary purpose is to test the hypothesis that oral administration of a low single dose of β-antagonist propranolol (40 mg) reduces pain sensitivity in patients with masticatory muscle pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Temporomandibular Joint Disorders

Currently open trials in the same condition.

NCT07317570 — The Effect of Body Awareness Therapy on Pain, Function and Psychosocial Parameters in Temporomandibular Joint Disorders · NA · recruiting
NCT06763419 — Internal Photobiomodulation For Management Of Temporomandibular Joint Internal Derangement · NA · recruiting
NCT06721104 — Balance, TMJ, Social Adaptive Assessment in Individuals With Autism Spectrum Disorder · recruiting
NCT06500390 — Temporomandibular Disorder in Use of Levonorgestrel Intrauterine System · NA · recruiting
NCT06813040 — Efficacy of Repetitive Transcranial Magnetic Stimulation in Temporomandibular Disorders. · NA · recruiting

Other University of Aarhus trials

Trials by the same sponsor.

NCT07209540 — European LUpuS Inception-Cohort Developing initiATivE · not yet recruiting
NCT07317401 — Investigating the Effects of Intermittent Hypoxia-Hyperoxia Treatment (IHHT) in People With Post-Viral Myalgic Encephalo · NA · not yet recruiting
NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
NCT07528339 — Prospective RegIstry for Oncologic Reirradiation (PRIOR-DK) · not yet recruiting
NCT07451028 — Effect of an Oral Neuromuscular Training Device on Dysphagia · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01333150 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Aarhus
Last refreshed: 23 March 2012

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01333150.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing